Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 179

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer

Open access
Pinato, David J., Zambelli, Alberto, Aguilar-Company, Juan, Bower, Mark, Sng, Christopher C.T., Salazar, Ramon, Bertuzzi, Alexia, Brunet, Joan, Mesia, Ricard, Seguí, Elia, Biello, Federica, Generali, Daniele, Grisanti, Salvatore, Rizzo, Gianpiero, Libertini, Michela, Maconi, Antonio, Harbeck, Nadia, Vincenzi, Bruno, Bertulli, Rossella, Ottaviani, Diego, Carbó, Anna, Bruna, Riccardo, Benafif, Sarah, Marrari, Andrea, Wuerstlein, Rachel, Carmona-Garcia, M. Carmen, Chopra, Neha, Tondini, Carlo, Mirallas, Oriol, Tovazzi, Valeria, Betti, Marta, Provenzano, Salvatore, Fotia, Vittoria, Cruz, Claudia Andrea, Dalla Pria, Alessia, D'Avanzo, Francesca, Evans, Joanne S., Saoudi-Gonzalez, Nadia, Felip, Eudald, Galazi, Myria, Garcia-Fructuoso, Isabel, Lee, Alvin J.X., Newsom-Davis, Thomas, Patriarca, Andrea, García-Illescas, David, Reyes, Roxana, Dileo, Palma, Sharkey, Rachel, Wong, Yien Ning Sophia, Ferrante, Daniela, Marco-Hernández, Javier, Sureda, Anna, Maluquer, Clara, Ruiz-Camps, Isabel, Gaidano, Gianluca, Rimassa, Lorenza, Chiudinelli, Lorenzo, Izuzquiza, Macarena, Cabirta, Alba, Franchi, Michela, Santoro, Armando, Prat, Aleix, Tabernero, Josep, Gennari, Alessandra, Avanzi, Gian Carlo, Bellan, Mattia, Castello, Luigi Mario, Martinez, Maria, Mollà, Meritxell, Pirisi, Mario, Scotti, Lorenza, Swallow, Judith · 2020 · Cancer Discovery

Published version of a preprint

Abstract

The SARS-CoV-2 pandemic significantly affected oncology practice across the globe. There is uncertainty as to the contribution of patients' demographics and oncologic features to severity and mortality from COVID-19 and little guidance as to the role of anticancer and anti–COVID-19 therapy in this population. In a multicenter study of 890 patients with cancer with confirmed COVID-19, we demonstrated a worsening gradient of mortality from breast cancer to hematologic malignancies and showed that male gender, older age, and number of comorbidities identify a subset of patients with significantly worse mortality rates from COVID-19. Provision of chemotherapy, targeted therapy, or immunotherapy did not worsen mortality. Exposure to antimalarials was associated with improved mortality rates independent of baseline prognostic factors. This study highlights the clinical utility of demographic factors for individualized risk stratification of patients and supports further research into emerging anti–COVID-19 therapeutics in SARS-CoV-2–infected patients with cancer. Significance: In this observational study of 890 patients with cancer diagnosed with SARS-CoV-2, mortality was 33.6% and predicted by male gender, age ≥65, and comorbidity burden. Delivery of cancer therapy was not detrimental to severity or mortality from COVID-19. These patients should be the focus of shielding efforts during the SARS-CoV-2 pandemic. This article is highlighted in the In This Issue feature, p. 1426

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-20-0773

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 24

  1. Lu, 2020, Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding, Lancet, 395, 565, 10.1016/S0140-6736(20)30251-8 · DOI · Paper page
  2. Lake, 2020, What we know so far: COVID-19 current clinical knowledge and research, Clin Med, 20, 124, 10.7861/clinmed.2019-coron · DOI · Paper page
  3. Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
  4. Ueda, 2020, Managing cancer care during the COVID-19 pandemic: agility and collaboration toward a common goal, J Natl Compr Canc Netw, 1
  5. van de Haar, 2020, Caring for patients with cancer in the COVID-19 era, Nat Med, 26, 665, 10.1038/s41591-020-0874-8 · DOI · Paper page
  6. Liang, 2020, Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China, Lancet Oncol, 21, 335, 10.1016/S1470-2045(20)30096-6 · DOI · Paper page
  7. Ferrari, 2020, Routine blood tests as a potential diagnostic tool for COVID-19, Clin Chem Lab Med, 58, 1095, 10.1515/cclm-2020-0398 · DOI · Paper page
  8. Hanna, 2020, Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic, Nat Rev Clin Oncol, 17, 268, 10.1038/s41571-020-0362-6 · DOI · Paper page
  9. Zhang, 2020, Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China, Ann Oncol, 31, 894, 10.1016/j.annonc.2020.03.296 · DOI · Paper page
  10. Bhatraju, 2020, Covid-19 in critically ill patients in the Seattle region - case series, N Engl J Med, 382, 2012, 10.1056/NEJMoa2004500 · DOI · Paper page
  11. Luo, 2020, Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers, Cancer Discov, 10, 1121, 10.1158/2159-8290.CD-20-0596 · DOI · Paper page
  12. Montopoli, 2020, Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n = 4532), Ann Oncol, 31, 1040, 10.1016/j.annonc.2020.04.479 · DOI · Paper page
  13. Safdar, 2011, Infections in patients with hematologic neoplasms and hematopoietic stem cell transplantation: neutropenia, humoral, and splenic defects, Clin Infect Dis, 53, 798, 10.1093/cid/cir492 · DOI
  14. Salvi, 2020, Emerging pharmacotherapies for COVID-19, Biomed Pharmacother, 128, 110267, 10.1016/j.biopha.2020.110267 · DOI
  15. Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282 · DOI · Paper page
  16. Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrob Agents, ;56, 105949, 10.1016/j.ijantimicag.2020.105949 · DOI · Paper page
  17. Mehra, 2020, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet
  18. Mehra, 2020, RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, Lancet
  19. Rome, 2020, Drug evaluation during the Covid-19 pandemic, N Engl J Med, 382, 2282, 10.1056/NEJMp2009457 · DOI · Paper page
  20. Wu, 2020, Risk Factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China, JAMA Intern Med, 180, 1, 10.1001/jamainternmed.2020.0994 · DOI · Paper page
  21. Sehatzadeh, 2014, Cardiopulmonary resuscitation in patients with terminal illness: an evidence-based analysis, Ont Health Technol Assess Ser, 14, 1
  22. Lewis, 2020, Between Scylla and Charybdis — Oncologic decision making in the time of Covid-19, N Engl J Med, 382, 2285, 10.1056/NEJMp2006588 · doi:10.1056/nejmp2006588
  23. Corman, 2020, Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, Euro Surveill, 25, 2000045, 10.2807/1560-7917.ES.2020.25.3.2000045 · DOI · Paper page
  24. Wang, 2020, Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, 323, 1061, 10.1001/jama.2020.1585 · DOI · Paper page

Cited by

See all 179

Metadata

Authors
Pinato, D. J., Zambelli, A., Aguilar-Company, J., Bower, M., Sng, C. C. T., Salazar, R., Bertuzzi, A., Brunet, J., Mesia, R., Seguí, E., Biello, F., Generali, D., Grisanti, S., Rizzo, G., Libertini, M., Maconi, A., Harbeck, N., Vincenzi, B., Bertulli, R., Ottaviani, D., Carbó, A., Bruna, R., Benafif, S., Marrari, A., Wuerstlein, R., Carmona-Garcia, M. C., Chopra, N., Tondini, C., Mirallas, O., Tovazzi, V., Betti, M., Provenzano, S., Fotia, V., Cruz, C. A., Dalla Pria, A., D'Avanzo, F., Evans, J. S., Saoudi-Gonzalez, N., Felip, E., Galazi, M., Garcia-Fructuoso, I., Lee, A. J. X., Newsom-Davis, T., Patriarca, A., García-Illescas, D., Reyes, R., Dileo, P., Sharkey, R., Wong, Y. N. S., Ferrante, D., Marco-Hernández, J., Sureda, A., Maluquer, C., Ruiz-Camps, I., Gaidano, G., Rimassa, L., Chiudinelli, L., Izuzquiza, M., Cabirta, A., Franchi, M., Santoro, A., Prat, A., Tabernero, J., Gennari, A., Avanzi, G. C., Bellan, M., Castello, L. M., Martinez, M., Mollà, M., Pirisi, M., Scotti, L., & Swallow, J.
Venue
Cancer Discovery
Published
2020-10-01
Volume
10
Issue
10
Pages
1465-1474
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W3046619251
Cited by
179
References
2
FWCI
12.59
Type
journal article
Language
en
Open access
bronze
Funders
  • Wellcome Trust (PS3416)
  • AIRC (21198, 14230)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer. https://app.cochat.ai/papers/10.1158/2159-8290.cd-20-0773
The paper
Pinato, D. J., Zambelli, A., Aguilar-Company, J., Bower, M., Sng, C. C. T., Salazar, R., Bertuzzi, A., Brunet, J., Mesia, R., Seguí, E., Biello, F., Generali, D., Grisanti, S., Rizzo, G., Libertini, M., Maconi, A., Harbeck, N., Vincenzi, B., Bertulli, R., . . . Swallow, J. (2020). Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-20-0773

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.